Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease
IntroductionQuercetin is a plant flavonoid and has potent antioxidant and anti-inflammatory properties. In a preclinical model of chronic obstructive pulmonary disease (COPD), quercetin reduced markers of both oxidative stress and lung inflammation and also reduced rhinovirus-induced progression of...
Main Authors: | Adam T Comstock, Fernando J Martinez, MeiLan K Han, Tyler A Barreto, Umadevi S Sajjan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/7/1/e000392.full |
Similar Items
-
Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype.
by: Mohammad Farazuddin, et al.
Published: (2018-01-01) -
Fish oil supplementation in chronic obstructive pulmonary disease: feasibility of conducting a randomised controlled trial
by: Ashley S. Fulton, et al.
Published: (2017-11-01) -
Feasibility of a randomised controlled trial of fish oil supplementation in people with chronic obstructive pulmonary disease
by: A.S. Fulton, et al.
Published: (2016-06-01) -
Enhancement of cellular adaptation to physical training in Chronic Obstructive Pulmonary Disease : a randomised placebo controlled trial of creatine supplementation
by: Deacon, Sarah Jane
Published: (2008) -
Magnesium for acute exacerbation of chronic obstructive pulmonary disease: A systematic review of randomised trials
by: Mitrakrishnan Chrishan Shivanthan, et al.
Published: (2014-01-01)